232 related articles for article (PubMed ID: 31161842)
1. Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease.
David C; Divard G; Abbas R; Escoubet B; Chezel J; Chauveheid MP; Rouzaud D; Boutten A; Papo T; Dehoux M; Sacre K
Scand J Rheumatol; 2020 Jan; 49(1):33-37. PubMed ID: 31161842
[No Abstract] [Full Text] [Related]
2. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.
Nishino A; Katsumata Y; Kawasumi H; Hirahara S; Kawaguchi Y; Yamanaka H
Lupus; 2019 Jul; 28(8):986-994. PubMed ID: 31246559
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study.
Divard G; Abbas R; Chenevier-Gobeaux C; Chanson N; Escoubet B; Chauveheid MP; Dossier A; Papo T; Dehoux M; Sacre K
Arthritis Res Ther; 2017 Jun; 19(1):132. PubMed ID: 28610589
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events.
Frerix M; Stegbauer J; Kreuter A; Weiner SM
Arthritis Res Ther; 2014 Feb; 16(1):R54. PubMed ID: 24548804
[TBL] [Abstract][Full Text] [Related]
5. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
[TBL] [Abstract][Full Text] [Related]
6. CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus.
Nakayama W; Jinnin M; Makino K; Kajihara I; Makino T; Fukushima S; Sakai K; Inoue Y; Ihn H
Eur J Dermatol; 2012; 22(4):512-7. PubMed ID: 22576016
[TBL] [Abstract][Full Text] [Related]
7. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.
McMahon M; Skaggs BJ; Grossman JM; Sahakian L; Fitzgerald J; Wong WK; Lourenco EV; Ragavendra N; Charles-Schoeman C; Gorn A; Karpouzas GA; Taylor MB; Watson KE; Weisman MH; Wallace DJ; Hahn BH
Arthritis Rheumatol; 2014 Jan; 66(1):130-9. PubMed ID: 24449580
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus.
Anania C; Gustafsson T; Hua X; Su J; Vikström M; de Faire U; Heimbürger M; Jogestrand T; Frostegård J
Arthritis Res Ther; 2010; 12(6):R214. PubMed ID: 21092251
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
Fischer K
Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
[TBL] [Abstract][Full Text] [Related]
10. Predictors of carotid atherosclerosis in systemic lupus erythematosus.
Maksimowicz-McKinnon K; Magder LS; Petri M
J Rheumatol; 2006 Dec; 33(12):2458-63. PubMed ID: 17014002
[TBL] [Abstract][Full Text] [Related]
11. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
[TBL] [Abstract][Full Text] [Related]
12. Human low-affinity IgG receptor FcγRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus.
Clancy R; El Bannoudi H; Rasmussen SE; Bornkamp N; Allen N; Dann R; Reynolds H; Buyon JP; Berger JS
J Thromb Haemost; 2019 Mar; 17(3):532-537. PubMed ID: 30638300
[TBL] [Abstract][Full Text] [Related]
13. The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.
Moreno JA; Muñoz-García B; Martín-Ventura JL; Madrigal-Matute J; Orbe J; Páramo JA; Ortega L; Egido J; Blanco-Colio LM
Atherosclerosis; 2009 Nov; 207(1):103-10. PubMed ID: 19473660
[TBL] [Abstract][Full Text] [Related]
14. Total plaque area and plaque echogenicity are novel measures of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Croca SC; Griffin M; Farinha F; Isenberg DA; Nicolaides A; Rahman A
Rheumatology (Oxford); 2021 Sep; 60(9):4185-4198. PubMed ID: 33404639
[TBL] [Abstract][Full Text] [Related]
15. [Soluble CD40 ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection].
Popkova TV; Panafidina TA; Aleksandrova EN; Novikova DS; Novikov AA; Alekberova ZS; Mach ES; Nasonov EL
Ter Arkh; 2008; 80(5):37-41. PubMed ID: 18590112
[TBL] [Abstract][Full Text] [Related]
16. Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease.
Urbonaviciene G; Martin-Ventura JL; Lindholt JS; Urbonavicius S; Moreno JA; Egido J; Blanco-Colio LM
Atherosclerosis; 2011 Dec; 219(2):892-9. PubMed ID: 21962403
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
[TBL] [Abstract][Full Text] [Related]
18. The association of high sCD163/sTWEAK ratio with cardiovascular disease in hemodialysis patients.
Rusu CC; Racasan S; Kacso IM; Ghervan L; Moldovan D; Potra A; Patiu IM; Bondor C; Caprioara MG
Int Urol Nephrol; 2015 Dec; 47(12):2023-30. PubMed ID: 26433887
[TBL] [Abstract][Full Text] [Related]
19. Dietary micronutrient intake and atherosclerosis in systemic lupus erythematosus.
Lourdudoss C; Elkan AC; Hafström I; Jogestrand T; Gustafsson T; van Vollenhoven R; Frostegård J
Lupus; 2016 Dec; 25(14):1602-1609. PubMed ID: 27334936
[TBL] [Abstract][Full Text] [Related]
20. Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus.
Jung JY; Koh BR; Bae CB; Kim HA; Suh CH
Lupus; 2014 Dec; 23(14):1517-22. PubMed ID: 25059488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
